Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators.
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerMechanisms of phthalate ester toxicity in the female reproductive systemRegulation of translocator protein 18 kDa (TSPO) expression in health and disease statesOxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2Peroxisome proliferator-activated receptor agonists prevent 25-OH-cholesterol induced c-jun activation and cell deathOverview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression.Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays.Reversal of high dietary fructose-induced PPARalpha suppression by oral administration of lipoxygenase/cyclooxygenase inhibitorsIncrease in class 2 aldehyde dehydrogenase expression by arachidonic acid in rat hepatoma cellsFenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infectionA replication study of GWAS-derived lipid genes in Asian Indians: the chromosomal region 11q23.3 harbors loci contributing to triglyceridesIdentification of modulators of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) in a mouse liver gene expression compendiumRole of thyroid hormones in hepatic effects of peroxisome proliferators.Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonistsOptimization of an enzyme-linked immunosorbent assay to screen ligand of Peroxisome proliferator-activated receptor alpha.Insulin, cognition, and dementiaTherapeutic Implications of PPARgamma in Human Osteosarcoma.PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor.PPARalpha: energy combustion, hypolipidemia, inflammation and cancerInhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemiaGene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent EffectsOverexpression of peroxisome proliferator-activated receptor-alpha (PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal bNonhuman primates and other animal models in diabetes research.Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors.Regulation of Proteome Maintenance Gene Expression by Activators of Peroxisome Proliferator-Activated Receptor α.Tissue expression of PPAR-α isoforms in Scophthalmus maximus and transcriptional response of target genes in the heart after exposure to WY-14643.Association of a genetic variant of the ZPR1 zinc finger gene with type 2 diabetes mellitus.Receptor-mediated hepatocarcinogenesis: role of hepatocyte proliferation and apoptosis.Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation.6-gingerol protects against nutritional steatohepatitis by regulating key genes related to inflammation and lipid metabolism.A critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosis.Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract?Association of FURIN and ZPR1 polymorphisms with metabolic syndrome.Suppression of peroxisomal enzyme activities and cytochrome P450 4A isozyme expression by congeneric polybrominated and polychlorinated biphenyls.The Functions of PPARs in Aging and Longevity.Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell linesPeroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents
P2860
Q21328702-F8E74D6C-1B88-45D7-A59B-594D27ED3B89Q24529989-DEF2FBAE-DC35-454A-BF17-341E70C51FBCQ24631648-81C9B647-4235-4ECE-8873-4BF144E50AB4Q24792721-42FC6F78-13EE-4216-9845-42D83886ECD9Q24795891-3D03FE1F-9003-4FBA-8A0C-3FFBD525F701Q24811518-E318CFD6-4DD6-442F-AA4B-218D2AD4E7A3Q24811528-72D0D082-9D88-41B5-9967-6BE774473C17Q24814568-C26A064A-70F4-476A-BADB-31748F42B277Q28344433-6587C9FB-425C-40FD-A95E-68D023B62AFEQ28482311-45AE3D10-B92C-4D66-AC1F-B213F5B77CBBQ28483829-46BAE268-097C-4775-BB93-D4DCBF70DD81Q28543435-56C84293-E20E-4643-992A-A5C178111E34Q32052567-67EB1B6A-7C65-4502-B6FF-00D90C4CFD8DQ33264199-D3A444D9-0B5E-4774-8514-5CFAD1AF2086Q33415147-40F9867E-B8F9-4A52-9974-91C77DA8DD41Q33604874-A029AD62-2577-4877-8403-28EDA91B6C46Q33674615-1B05464C-FC75-47F3-9A29-80EC10B659B4Q33746525-169838F2-34C0-421E-9A14-F44188581C92Q33805104-E76967E6-110D-40FC-8B90-712EEEBA998FQ33967999-CD9D21D4-CDFB-4501-B036-52D4372D465DQ34011517-FCA85183-53CB-4B8A-BC4D-AC5AFADE985AQ34170165-14F64A8E-AC5F-4AF7-9468-8C37DE3A9535Q34263929-943B0DCB-8503-4C58-8D15-0B47C6ECAC73Q34286456-D7C01386-C39F-42EB-894E-116919AA2B2AQ34339895-3D7E1BCA-698B-4D54-B193-9A0E0CB0CE97Q34521305-9735FB11-03F0-43E3-A729-95D574014010Q34522586-795DCD44-8E26-4A99-A1B6-A67B04967C12Q34607502-07E2B50B-7F49-4E92-9656-E974EDC74E24Q34794627-A731DB44-176E-4667-87B0-538712688565Q34986711-EDA5BEEC-6CA5-40A6-924D-5418CCE8E59AQ35131341-50314B42-0109-4169-9BB4-C39846087D44Q35222107-E0B7D16F-84AD-4640-8F46-E6D6FD38F5F2Q35924008-ABA15847-1B9A-4FF9-97EF-0CC1399233F1Q35948075-D0AE1401-D250-4C77-81EE-E20F36313F7CQ36417508-0FC7AFED-FE39-4F9D-85F2-E49E54B07A31Q36478394-6FB1051B-53B6-48B7-9667-D71C3E8BC58AQ36687379-108DDE6E-ACA6-4054-85A3-30DE8EC2C378Q36695847-ADC16FBF-0E73-4026-9C82-D7A57B440BD1Q36724770-933FEB63-0901-4D20-8FC6-2AA926CA6BFFQ36859555-C0F07567-339D-4214-9A45-D48D1251CCAD
P2860
Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Central role of peroxisome pro ...... s of peroxisome proliferators.
@ast
Central role of peroxisome pro ...... s of peroxisome proliferators.
@en
type
label
Central role of peroxisome pro ...... s of peroxisome proliferators.
@ast
Central role of peroxisome pro ...... s of peroxisome proliferators.
@en
prefLabel
Central role of peroxisome pro ...... s of peroxisome proliferators.
@ast
Central role of peroxisome pro ...... s of peroxisome proliferators.
@en
P2093
P1476
Central role of peroxisome pro ...... s of peroxisome proliferators.
@en
P2093
P304
P356
10.1146/ANNUREV.PHARMTOX.40.1.491
P577
2000-01-01T00:00:00Z